The European Medicines Agency (EMA) approved on Thursday the Spanish laboratory HIPRA's Covid-19 booster vaccine, commercially known as BIMERVAX.
BIMERVAX has a lab-created protein consisting of a section of the Sars-CoV-2 spike protein from the Alpha and Beta variants of the virus....
The European Commission announced Tuesday it signed a joint procurement contract with HIPRA for the supply of its protein-based COVID-19 vaccine amid the increasing number of coronavirus cases in Europe.
Under the joint procurement, 14 member states will be able to buy up to 250 million...
The European Medicines Agency (EMA) announced on Tuesday it has started a real-time review of the COVID-19 vaccine developed by Spanish pharmaceutical company Hipra.
While the EMA didn't provide a timeline on when the jab could be approved, the agency confirmed the vaccine would...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
